News
Lubrizol Life Science Health awarded grant for generic contraceptive injection research to advance women’s health worldwide
The Lubrizol Corporation has announced that the contract development and manufacturing organization (CDMO) of Lubrizol Life Science Health (LLS Health) has been awarded a grant to support its research on injectable contraceptive formulations designed to bring accessible contraceptive products...
News
Botanical Solution Inc. (BSI) Appoints Marcus Meadows-Smith to their Board
Botanical Solution Inc. (BSI), an innovator of sustainable, highly consistent and cost effective Advanced Botanical Materials (ABM), has appointed Marcus Meadows-Smith to its Board of Directors. As a proven, successful, and recognized leader within the agrochemical industry, Meadows-Smith will...
News
iBio to Advance COVID-19 LicKM-Subunit Vaccine Candidate, IBIO-201
iBio, Inc., a biotech innovator and biologics contract manufacturing organization, announced that it has selected IBIO-201, its LicKM™-ubunit vaccine, as its leading candidate for the prevention of SARS-CoV-2 infection.
iBio previously announced that preclinical immunization studies with IBIO-200 and IBIO-201,...
News
ECCRT and IDDI establish partnership for continuous development of IDDI global team members
European Centre for Clinical Research Training (ECCRT) has been selected as a premium provider for continuous online learning by IDDI, a BIOSTATISTICAL AND ECLINICAL SERVICES provider for Pharmaceutical and Biotechnology companies.
ECCRT will provide access to the eLearning ‘Virtual Campus’...
News
Catalent Invests $130 Million to Add Additional Manufacturing Capacity at its Gene Therapy Campus in Harmans, Maryland
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it is investing $130 million to add five additional Phase 3 through commercial-scale...
News
Sheba Medical Center Treats First Patient with CAR-T Cell Immunotherapy Manufactured Using the Lonza Cocoon Platform
“Treatment of the first patient is a significant milestone for Lonza and demonstrates the Cocoon’s capability to manufacture patient-scale cellular immunotherapies in a cGMP setting for clinical use. Moreover, this project has demonstrated the feasibility and attractiveness of moving...
News
Oxford University vaccine trial paused after participant falls ill
Final clinical trials for a coronavirus vaccine, developed by AstraZeneca and Oxford University, have been put on hold after a participant had a suspected adverse reaction in the UK.
AstraZeneca described it as a "routine" pause in the case of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read